Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Tesamorelin + Ipamorelin Blend: Dosing Comparison

Tesamorelin 1mg (1mL) Once daily 30 min pre-breakfast, fasted 1mg:1mL with bacteriostatic water 7–10 days (use within this window) Primary GHRH agonist. Short half-life requires daily dosing; prepare fresh weekly Ipamorelin 200–300mcg (0.2–0.3mL) Twice daily M

This comparison does not assign a generated winner or score.

  • Tesamorelin
  • 1mg (1mL)
  • Once daily
  • 30 min pre-breakfast, fasted
  • 1mg:1mL with bacteriostatic water
  • 7–10 days (use within this window)
  • Primary GHRH agonist. Short half-life requires daily dosing; prepare fresh weekly
  • Ipamorelin
  • 200–300mcg (0.2–0.3mL)
  • Twice daily
  • Morning (concurrent with tesamorelin) + immediately before bed, fasted
  • 28 days
  • Ghrelin mimetic. Stable in solution; bedtime dose critical for overnight GH surge
  • Blended Protocols
  • Combined as above
  • Staggered (AM + PM for ipamorelin)
  • Must avoid insulin spikes (≥2 hrs post-meal)
  • Separate vials. Never pre-mix
  • Follow shortest stability window (tesamorelin = 7–10 days)
  • Synergistic when timed correctly; overlapping doses at same timepoint reduce efficacy due to receptor saturation
More references

Related material